BioPharm International
February 01, 2012
Issue PDF
25
2
Investing in BioPharma Outsourcing
February 01, 2012
Features
25
2
Stephen Taylor PhD, vice-president and commercial director at Fujifilm Diosynth Biotechnologies, addresses some of the challenges facing biologics outsourcing.
February 01, 2012
Perspectives on Outsourcing
25
2
Industry optimism is on the rise for 2012.
February 01, 2012
Features
25
2
China's healthcare reforms generate uncertainty for its domestic pharmaceutical market.
February 01, 2012
Features
25
2
The census reveals the state of the population of India's health and the potential for growth in the healthcare market.
February 01, 2012
Final Word
25
2
New educational programs are key to the industry's future and to safe, available drugs.
February 01, 2012
Features
25
2
Strategies for transfer of the manufacturing process.
February 01, 2012
Features
25
2
A Risk-Management Case Study.
February 01, 2012
Features
25
2
This article is the second in a two-part series on extractables and leachables.
February 01, 2012
From the Editor
25
2
Industry announces plans for year ahead at annual JPMorgan Global Healthcare Conference.
February 01, 2012
Disposables Advisor
25
2
This article outlines methods, validation standards, and documentation of sterilization of single-use products using gamma irradiation.
February 01, 2012
Features
25
2
This month, we revisit "Industrial-Scale Mammalian Cell Culture, Part I: Bioreactor Design Considerations."
February 01, 2012
Manufacturing Best Practices
25
2
Introducing a new way to think about sharing information in a patent-driven industry.
February 01, 2012
Regulatory Beat
25
2
More collaboration and expanded oversight aim to compel manufacturers to follow GMPs.
February 01, 2012
Features
25
2
The difficulties of doing business in China are offset by its adoption of more stringent GMP standards.